67 related articles for article (PubMed ID: 6834268)
1. 1-[4-(2-ter-butyl-quinolyl)]-3-(4-piperidyl)propanol (PK 10139): a new potent and long-acting antiarrhythmic agent.
Mestre M; Bouetard G; Le Fur G; Renault C; Gueremy C; Uzan A
J Pharmacol Exp Ther; 1983 Apr; 225(1):158-63. PubMed ID: 6834268
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiologic, antiarrhythmic and cardiovascular actions of UM301, a quaternary ammonium compound.
Gibson JK; Patterson E; Lucchesi BR
J Pharmacol Exp Ther; 1986 Apr; 237(1):318-25. PubMed ID: 3754279
[TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmic, electrophysiologic and hemodynamic effects of ACC-9358.
Brown BS; Calzadilla SV; Diemer MJ; Hartman JC; Reynolds RD
J Pharmacol Exp Ther; 1987 Dec; 243(3):1225-34. PubMed ID: 3694532
[TBL] [Abstract][Full Text] [Related]
4. N-(2,6-Dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165): a new potent and long-acting antiarrhythmic agent.
Aisaka K; Hidaka T; Inomata N; Hamasaki S; Ishihara T; Morita M
Arzneimittelforschung; 1985; 35(8):1239-45. PubMed ID: 4074441
[TBL] [Abstract][Full Text] [Related]
5. Indecainide: effects on arrhythmias, electrophysiology, and cardiovascular dynamics.
Holland DR; Lacefield WB; Gonzales CR; Johnston SR; Turk JA
J Cardiovasc Pharmacol; 1989 Sep; 14(3):454-61. PubMed ID: 2476626
[TBL] [Abstract][Full Text] [Related]
6. [Electrophysiological effects of encainide in man].
Cassagneau B; Calazel J; Puel J; Massabuau P; Miquel JP; Bounhoure JP; Marin T; Narula OS
Arch Mal Coeur Vaiss; 1984 Jun; 77(6):707-11. PubMed ID: 6431937
[TBL] [Abstract][Full Text] [Related]
7. [Electrophysiological effects of anti-arrhythmia agents in man. Attempt at classification].
Touboul P; Attalah G; Gressard A; Michelon G; Chatelain MT; Delahaye JP
Arch Mal Coeur Vaiss; 1979 Jan; 72(1):72-81. PubMed ID: 107885
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the antiarrhythmic activity of quinidine and quinine.
Klevans LR; Kelly RJ; Kovacs JL
Arch Int Pharmacodyn Ther; 1977 May; 227(1):57-68. PubMed ID: 901074
[TBL] [Abstract][Full Text] [Related]
9. Effect of 8-(3-diethylaminopropyl)-6,6-dimethyl-(2-phenyl-1 H-imidazo(4,5 h))isoquinoline-7,9-(6H)-dione dihydrochloride (AR-LH31) on experimental cardiac arrhythmias in dogs.
Kerr MJ; Harron DW; Wilson R; Shanks RG
Arzneimittelforschung; 1985; 35(1A):197-200. PubMed ID: 3838674
[TBL] [Abstract][Full Text] [Related]
10. [Quinidine plasma concentration-cardiac electrophysiologic effects relationships in anesthetized dogs (author's transl)].
Jaillon P; Heckle J; Juliard JM; Aubry JP; Weissenburger J; Cheymol G
J Pharmacol; 1982; 13(2):277-89. PubMed ID: 7098487
[TBL] [Abstract][Full Text] [Related]
11. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
Gambhir DS; Bhargava M; Nair M; Arora R; Khalilullah M
Indian Heart J; 1996; 48(2):133-7. PubMed ID: 8682552
[TBL] [Abstract][Full Text] [Related]
12. Comparative cardiac electrophysiologic study of PK 10139, a new antiarrhythmic agent, and quinidine in anesthetized dogs: plasma concentration-response relationships.
Heckle J; Jaillon P; Jozefczak C; Cheymol G
J Cardiovasc Pharmacol; 1985; 7(1):18-25. PubMed ID: 2580140
[TBL] [Abstract][Full Text] [Related]
13. Atrial, SA nodal, and AV nodal electrophysiology in standing horses: normal findings and electrophysiologic effects of quinidine and diltiazem.
Schwarzwald CC; Hamlin RL; Bonagura JD; Nishijima Y; Meadows C; Carnes CA
J Vet Intern Med; 2007; 21(1):166-75. PubMed ID: 17338165
[TBL] [Abstract][Full Text] [Related]
14. [Effects of nizofenone on experimental arrhythmia in dogs].
Nakamura T; Tsumagari T
Nihon Yakurigaku Zasshi; 1984 Nov; 84(5):441-51. PubMed ID: 6097519
[TBL] [Abstract][Full Text] [Related]
15. Pirmenol hydrochloride (CI-845): antiarrhythmic profile in coronary artery ligated conscious dogs.
Mertz TE; Steffe TJ
J Cardiovasc Pharmacol; 1980; 2(5):527-41. PubMed ID: 6157947
[TBL] [Abstract][Full Text] [Related]
16. Atrial inputs as determinants of atrioventricular nodal conduction: re-evaluation and new concepts.
Scherlag BJ; Antz M; Otomo K; Tondo C; Patterson E; Lazzara R; Jackman WM
Cardiologia; 1995 Oct; 40(10):753-61. PubMed ID: 8819736
[TBL] [Abstract][Full Text] [Related]
17. Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499].
Lynch JJ; Wallace AA; Stupienski RF; Baskin EP; Beare CM; Appleby SD; Salata JJ; Jurkiewicz NK; Sanguinetti MC; Stein RB
J Pharmacol Exp Ther; 1994 May; 269(2):541-54. PubMed ID: 7802864
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiology of tiapamil in humans.
Lévy S; Burtey JP; Labrunie P; Faugère G; Valeix B; Cano JP; Gérard R
Cardiology; 1982; 69 Suppl():117-23. PubMed ID: 7151072
[TBL] [Abstract][Full Text] [Related]
19. [Exogenous adenosine as an anti-arrhythmia agent].
Tebbenjohanns J; Pfeiffer D; Schumacher B; Korte T; Jung W; Lüderitz B
Z Kardiol; 1996; 85 Suppl 6():191-9. PubMed ID: 9064965
[TBL] [Abstract][Full Text] [Related]
20. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
